IRES-mediated translation of utrophin A is enhanced by glucocorticoid treatment in skeletal muscle cells.
Glucocorticoids are currently the only drug treatment recognized to benefit Duchenne muscular dystrophy (DMD) patients. The nature of the mechanisms underlying the beneficial effects remains incompletely understood but may involve an increase in the expression of utrophin. Here, we show that treatme...
Main Authors: | Pedro Miura, Meghan Andrews, Martin Holcik, Bernard J Jasmin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2008-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2396518?pdf=render |
Similar Items
-
Skeletal Muscle Specific IRES Activity of Utrophin A Is Enhanced by Eef1a2
by: Coriati, Adèle
Published: (2011) -
Skeletal Muscle Specific IRES Activity of Utrophin A Is Enhanced by Eef1a2
by: Coriati, Adèle
Published: (2011) -
Skeletal Muscle Specific IRES Activity of Utrophin A Is Enhanced by Eef1a2
by: Coriati, Adèle
Published: (2011) -
Skeletal Muscle Specific IRES Activity of Utrophin A Is Enhanced by Eef1a2
by: Coriati, Adèle
Published: (2011) -
Identification of therapeutics that target eEF1A2 and upregulate utrophin A translation in dystrophic muscles
by: Christine Péladeau, et al.
Published: (2020-04-01)